HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linqian Hou Selected Research

Rhabdomyolysis

1/2021Ultra-small natural product based coordination polymer nanodots for acute kidney injury relief.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linqian Hou Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 11/2019
2Inflammation (Inflammations)
01/2023 - 01/2022
1Stroke (Strokes)
02/2023
1Ischemia
02/2023
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2023
1Reperfusion Injury
02/2023
1Wounds and Injuries (Trauma)
01/2023
1Colitis
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Rhabdomyolysis
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021

Drug/Important Bio-Agent (IBA)

5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2023 - 01/2021
2PolymersIBA
02/2023 - 01/2021
2CytokinesIBA
01/2023 - 01/2022
1IronIBA
02/2023
1ChloridesIBA
02/2023
1Gallic AcidIBA
02/2023
1CollagenIBA
01/2023
1titanium carbideIBA
01/2022
1ElementsIBA
01/2022
1EnzymesIBA
01/2022
1Glutathione (Reduced Glutathione)IBA
01/2022
1HydrogenIBA
01/2022
1SaltsIBA
01/2022
1VanadiumIBA
01/2022
1Dextran SulfateIBA
01/2022
1Toll-Like Receptor 9IBA
11/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2021
1Cancer VaccinesIBA
11/2021
1CPG-oligonucleotideIBA
11/2021
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
11/2021
1VaccinesIBA
11/2021
1Cell Adhesion MoleculesIBA
11/2021
1NanovaccinesIBA
11/2021
1Immune Checkpoint InhibitorsIBA
11/2021
1CurcuminIBA
01/2021
1Photosensitizing Agents (Photosensitizers)IBA
11/2019

Therapy/Procedure

6Therapeutics
02/2023 - 11/2019
1Aftercare (After-Treatment)
02/2023
1Oral Administration
01/2022
1Immunotherapy
11/2021
1Precision Medicine
11/2020